Observational Study for Slipped Capital Femoral Epiphysis
(SLIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the best ways to treat Slipped Capital Femoral Epiphysis (SCFE), a hip condition common in teens. Researchers seek to determine which surgical treatments are most effective and have fewer long-term complications, such as avascular necrosis (bone death due to lack of blood flow) or joint issues. The trial will observe patients who are newly diagnosed, those treated at participating centers, and those treated elsewhere but continuing care at a participating center. This trial suits anyone under 18 diagnosed with SCFE who plans to receive follow-up care at one of the centers involved in the study. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the chance to contribute to a potentially groundbreaking treatment.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to gather comprehensive data on patients with Slipped Capital Femoral Epiphysis (SCFE) through a unique observational approach. Unlike typical treatment studies focused on testing new medications or surgical techniques, this registry tracks patients from diagnosis and through various treatment experiences, whether at the initial or outside centers. By following patients over time, the trial seeks to better understand the long-term outcomes of different treatment paths, potentially improving future care strategies for SCFE. This approach could reveal patterns and insights that current treatment studies might miss, leading to more personalized and effective treatment plans.
Who Is on the Research Team?
Kishore Mulpuri, FRCSC
Principal Investigator
Principal Investigator
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Registry Enrollment
Participants are enrolled into the international prospective registry for SCFE
Treatment
Participants receive surgical treatment options such as in-situ pinning or the Modified Dunn procedure
Follow-up
Participants are monitored for clinical, functional, and radiographic outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Observational
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Patients who have received previous treatment at an outside center but are continuing treatment at a participating center will be placed into Arm III.
Patients who have received previous treatment and will continue to receive treatment at the participating center will be placed into Arm II.
Patients have been enrolled and followed since diagnosis will be placed into Arm I.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.